Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

994 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
[Osteoprotection in patients with bone metastatic castration-resistant prostate cancer (mCRPC): real-world data from Germany, presented by d-uo].
Doehn C, Klier J, Johannsen M, Eichenauer R, Schönfelder R, Romagnolo A, Reese S, Nitz C, Jaeger A, Fieseler C, Burkert-Scholz M, Brenneis H, Binder M, Beuke M, Schröder J, Hempel E, König F. Doehn C, et al. Among authors: binder m. Aktuelle Urol. 2022 Dec;53(6):526-534. doi: 10.1055/a-1949-7814. Epub 2022 Nov 24. Aktuelle Urol. 2022. PMID: 36423613 German.
[Osteoprotection in patients with non-metastatic hormone-sensitive prostate cancer (mHSPC) receiving androgen-deprivation therapy (ADT): Real-world data from Germany, presented by d-uo].
Klier J, König F, Schönfelder R, Eichenauer R, Johannsen M, Beuke M, Binder M, Brenneis H, Burkert-Scholz M, Fieseler C, Jaeger A, Nitz C, Reese S, Romagnolo A, Schröder J, Hempel E, Doehn C. Klier J, et al. Among authors: binder m. Aktuelle Urol. 2022 Dec;53(6):517-525. doi: 10.1055/a-1954-6826. Epub 2022 Nov 24. Aktuelle Urol. 2022. PMID: 36423612 German.
Elevated Soluble ACE2 Activity in Children and Adults After SARS-CoV-2 Exposure Irrespective of Laboratory-Confirmed Infection.
Stich M, Magalhães VG, Bürger F, Garbade SF, Jeltsch K, Mohr K, Haddad A, Elling R, Lang P, Rabsteyn A, Jacobsen EM, Bode SFN, Müller B, Kräusslich HG, Hoffmann GF, Okun JG, Bartenschlager R, Binder M, Janda A, Renk H, Tönshoff B. Stich M, et al. Among authors: binder m. J Med Virol. 2024 Dec;96(12):e70098. doi: 10.1002/jmv.70098. J Med Virol. 2024. PMID: 39624009
Post-COVID recovery is faster after an infection with the SARS-CoV-2 Omicron variant: a population-based cohort study.
Pfrommer LR, Diexer S, Klee B, Massag J, Gottschick C, Purschke O, Binder M, Frese T, Girndt M, Sedding D, Rosendahl J, Hoell JI, Moor I, Gekle M, Allwang C, Junne F, Mikolajczyk R. Pfrommer LR, et al. Among authors: binder m. Infection. 2024 Nov 18. doi: 10.1007/s15010-024-02438-z. Online ahead of print. Infection. 2024. PMID: 39556163
Retreatment of Multiple Myeloma with Previously Refractory Drugs.
Goel U, Charalampous C, Kapoor P, Binder M, Buadi FK, Dingli D, Dispenzieri A, Fonder AL, Gertz MA, Gonsalves WI, Hayman SR, Hobbs MA, Hwa YL, Kourelis TV, Lacy MQ, Leung N, Lin Y, Warsame R, Kyle RA, Rajkumar SV, Kumar SK. Goel U, et al. Among authors: binder m. Blood Adv. 2024 Nov 13:bloodadvances.2024014723. doi: 10.1182/bloodadvances.2024014723. Online ahead of print. Blood Adv. 2024. PMID: 39536293
Inflammatory stress determines the need for chemotherapy in patients with HER2-positive esophagogastric adenocarcinoma receiving targeted and immunotherapy.
Tintelnot J, Paschold L, Goekkurt E, Schultheiss C, Matschl U, Santos Cruz M, Bauer M, Wickenhauser C, Thuss-Patience P, Lorenzen S, Ettrich TJ, Riera-Knorrenschild J, Jacobasch L, Kretzschmar A, Kubicka S, Al-Batran SE, Reinacher-Schick A, Pink D, Bokemeyer C, Sinn M, Lindig U, Hinke A, Hegewisch-Becker S, Stein A, Binder M. Tintelnot J, et al. Among authors: binder m. Cancer Immunol Res. 2024 Nov 11. doi: 10.1158/2326-6066.CIR-24-0561. Online ahead of print. Cancer Immunol Res. 2024. PMID: 39527097
In situ visualization of endothelial cell-derived extracellular vesicle formation in steady state and malignant conditions.
Atkin-Smith GK, Santavanond JP, Light A, Rimes JS, Samson AL, Er J, Liu J, Johnson DN, Le Page M, Rajasekhar P, Yip RKH, Geoghegan ND, Rogers KL, Chang C, Bryant VL, Margetts M, Keightley MC, Kilpatrick TJ, Binder MD, Tran S, Lee EF, Fairlie WD, Ozkocak DC, Wei AH, Hawkins ED, Poon IKH. Atkin-Smith GK, et al. Among authors: binder md. Nat Commun. 2024 Oct 22;15(1):8802. doi: 10.1038/s41467-024-52867-5. Nat Commun. 2024. PMID: 39438460 Free PMC article.
994 results